Robert A. Zittoun

Robert A. Zittoun's AcademicInfluence.com Rankings

Robert A. Zittoun

Philosophy

#9241

World Rank

#12774

Historical Rank

Logic

#6229

World Rank

#7728

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Robert A. Zittoun Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert A. Zittoun's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. (1995) (862)
Symptoms of anxiety and depression in family members of intensive care unit patients: Ethical hypothesis regarding decision-making capacity (2001) (669)
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. (1989) (383)
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. (2003) (368)
Modulation of multidrug-resistant multiple myeloma by cyclosporin (1992) (334)
Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity (1991) (300)
Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system (1996) (300)
Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia (1998) (280)
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and (1998) (271)
Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. (1998) (222)
Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. (1991) (213)
Compliance with triage to intensive care recommendations (2001) (195)
Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. (1999) (182)
Acquired hemophilia due to factor VIII inhibitors in 34 patients. (1998) (180)
Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. (1998) (163)
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. (1998) (162)
Overexpression of cyclin D2 in chronic B-cell malignancies. (1995) (161)
The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. (2000) (156)
Efficacy of Prevention by High-Efficiency Particulate Air Filtration or Laminar Airflow Against Aspergillus Airborne Contamination During Hospital Renovation (1999) (156)
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. (2001) (153)
Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P‐glycoprotein over‐expression (1998) (142)
A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia (1996) (142)
Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients (1994) (133)
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG). (1995) (131)
Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10. (2009) (131)
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group. (1996) (123)
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial (1997) (120)
Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone (1999) (119)
Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. (1995) (113)
Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. (1992) (104)
Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. (1985) (104)
Modern clinical testing strategies in cobalamin and folate deficiency. (1999) (104)
Folate metabolism. (1972) (98)
Assessment of quality of life during intensive chemotherapy or bone marrow transplantation (1999) (98)
French intensivists do not apply American recommendations regarding decisions to forgo life-sustaining therapy (2001) (97)
The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA (1998) (97)
Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy. (1986) (97)
Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study. (1996) (92)
Homoharringtonine: an effective new natural product in cancer chemotherapy. (1995) (90)
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893). (1997) (90)
SUBACUTE AND CHRONIC MYELOMONOCYTIC LEUKAEMIA: A DISTINCT HAEMATOLOGICAL ENTITY (1976) (76)
Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial. (2004) (76)
Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression. (1993) (75)
MDR1/P-glycoprotein in haematological neoplasms. (1996) (74)
Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group. (1989) (74)
Prediction of the response to chemotherapy in acute leukemia (1975) (72)
Splenic Marginal Zone Lymphoma With or Without Plasmacytic Differentiation (2000) (68)
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial (2003) (67)
Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group. (1989) (67)
Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period (1999) (64)
Expression of the multidrug resistance‐associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells (1996) (64)
Multidrug resistance gene expression in acute myeloid leukemia: Major prognosis significance for in vivo drug resistance to induction treatment (1997) (60)
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial (1996) (59)
Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. (1989) (58)
Effect of folate and cobalamin compounds on the deoxyuridine suppression test in vitamin B12 and folate deficiency. (1978) (57)
Occupational risk factors for acute leukaemia: a case-control study. (1992) (57)
Prognostic value of cytologic parameters in acute myelogenous leukemia (1984) (56)
Spontaneous remission in adult acute leukemia (1985) (55)
Sequential emergence of MRP‐ and MDR1‐gene over‐expression as well as MDR1‐gene translocation in homoharringtonine‐selected K562 human leukemia cell lines (1996) (55)
Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years (1997) (52)
The Three Transcobalamins in Myeloproliferative Disorders and Acute Leukaemia (1975) (49)
Role of MRP1 in multidrug resistance in acute myeloid leukemia (1999) (48)
Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties. (1989) (48)
PREGNANCY DURING MYELOSUPPRESSIVE TREATMENT FOR CHRONIC MYELOGENOUS LEUKAEMIA (1992) (47)
Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder (1999) (46)
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia: A leukemia‐lymphoma group trial of the EORTC (1986) (44)
Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group. (1999) (44)
In vitro culture of clonogenic leukaemic cells in acute myeloid leukaemia: growth pattern and drug sensitivity (1983) (44)
Heterogeneity of the in vitro responses to glucocorticoids in acute leukemia. (1980) (42)
Normal Human Bone Marrow Cultures in Vitro: Cellular Composition and Maturation of the Granulocytic Colonies (1977) (40)
Prognostic factors in elderly acute lymphoblastic leukaemia (1997) (40)
N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin. (1993) (39)
Lung resistance protein (LRP) gene expression in adult acute myeloid leukemia: a critical evaluation by three techniques (1998) (38)
DECREASE IN PROTEIN C IN L‐ASPARAGINASE‐TREATED PATIENTS (1985) (37)
Over‐expression of cyclin D1 in chronic B‐cell malignancies with abnormality of chromosome 11q13 (1995) (37)
Amsacrine with high-dose cytarabine in acute leukemia. (1985) (36)
Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody. (1989) (35)
Determination of ultrastructural peroxidases and immunologic membrane markers in the diagnosis of acute leukemias. (1982) (34)
Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine. (1995) (34)
Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. (1984) (33)
Acute leukaemia in workers exposed to electromagnetic fields. (1990) (33)
Acquired von willebrand disease: Correction of hemostatic defect by high‐dose intravenous immunoglobulins (1992) (33)
Treatment of agnogenic myeloid metaplasia with danazol: A report of four cases (1996) (32)
Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias. (1994) (31)
Peripheral T-cell lymphoma presenting as hypereosinophilia with vasculitis. (1988) (30)
Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias. (1995) (30)
Adult acute leukemia. (1994) (29)
Iron supplements versus placebo during pregnancy: its effects on iron and folate status on mothers and newborns. (1983) (29)
Malignant lymphoplasmacytic lymphoma with prominent splenomegaly (primary lymphoma of the spleen) (1988) (29)
A modular questionnaire for the assessment of longterm quality of life in leukaemia patients: The MRC/EORTC QLQ-LEU (1996) (28)
Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients (1989) (27)
[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials]. (1987) (27)
m-AMSA: a review of clinical data. (1985) (27)
Fournier's gangrene during induction treatment of acute promyelocytic leukemia, a case report (1998) (27)
Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II study. (1988) (25)
Full-term pregnancy with embryos from donated oocytes in a 36-year-old woman allografted for chronic myeloid leukemia. (1994) (24)
[Dural venous sinus occlusions in hemopathies]. (1985) (24)
Primary adrenal lymphoma. (1992) (24)
In vitro effect of P-glycoprotein (P-gp) modulators on drug sensitivity of leukemic progenitors (CFU-L) in acute myelogenous leukemia (AML). (1992) (23)
Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome (2000) (23)
Separation of Mononuclear Bone Marrow Cells using the Cobe 2997 Blood Cell Separator (1988) (23)
Idiopathic thrombocytopenic purpura as the presenting feature of a primary bilateral adrenal non Hodgkin's lymphoma. (1997) (23)
Recombinant interferon-α–induced chorea and frontal subcortical dementia (2002) (23)
Fatigue in cancer patients. (1999) (22)
Bone marrow involvement by disseminated toxoplasmosis in acquired immunodeficiency syndrome: the value of bone marrow trephine biopsy and immunohistochemistry for the diagnosis. (1996) (22)
Both P-gp and MRP contribute to drug resistance in AML (1998) (22)
High incidence of infectious gastrointestinal complications observed in patients with acute myeloid leukemia receiving intensive chemotherapy for first induction of remission (1996) (22)
High-dose cytarabine in acute leukemia: toxicity and pharmacokinetics. (1983) (21)
Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS). (1996) (21)
Chronic neutrophilic leukemia (1994) (20)
Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations. (1985) (20)
Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia. (1987) (19)
Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells (1997) (19)
GLUTATHIONE S-TRANSFERASES P, ALPHA, MU, AND MDR1 MRNA EXPRESSION IN NORMAL LYMPHOCYTES AND CHRONIC LYMPHOCYTIC LEUKEMIA (1995) (19)
Relationship of histological subtypes to prognosis in early stage Hodgkin's disease: a review of 312 cases in a controlled clinical trial. The Groupe Pierre et Marie Curie. (1989) (19)
The Intracellular Content of the Three Transcobalamins at Various Stages of Normal and Leukaemic Myeloid Cell Development (1975) (19)
A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC. (1997) (19)
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients (1999) (18)
Hepatic lesions of vascular origin in multicentric Castleman's disease, plasma cell type: report of one case with peliosis hepatis and another with perisinusoidal fibrosis and nodular regenerative hyperplasia. (1995) (18)
A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia (1992) (18)
Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). (1997) (17)
MDR-related P170-glycoprotein modulates cytotoxic activity of homoharringtonine. (1995) (17)
Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer. (2000) (17)
Recurrent spleen enlargement during cyclic granulocyte‐macrophage colony‐stimulating factor therapy for myelodysplastic syndrome (1990) (17)
Atypical T‐cell leukemia terminating Hodgkin's disease (1979) (16)
Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group. (1992) (16)
Expression of resistance genes in acute leukemia. (1994) (16)
Platelet Transfusions in Advanced Hematological Malignancies: A Position Paper (1996) (16)
Histopathological study of bone marrow biopsies in 30 cases of T‐cell lymphoma with clinical, biological and survival correlations (2006) (16)
Thymidylate Synthesis in a Folate Deprived Cell Line (1981) (16)
Modulation of 1-beta-D-arabinofuranosylcytosine metabolism by thymidine in human acute leukemia. (1985) (16)
Specific cutaneous involvement indicating relapse of Burkitt's lymphoma (1997) (16)
Ethical and Clinical Aspects of Intensive Care Unit Admission in Patients with Hematological Malignancies: Guidelines of the Ethics Commission of the French Society of Hematology (2014) (16)
Multidrug resistance (MDR) gene expression in acute non lymphoblastic leukemia: sequential analysis. (1992) (15)
Simultaneous Activity of MRP 1 and Pgp Is Correlated With In Vitro Resistance to Daunorubicin and With In Vivo Resistance in Adult Acute Myeloid Leukemia (1999) (15)
Combination of ABVD and radiotherapy in early stages of Hodgkin's disease: analysis of a series of 94 patients. Pierre and Marie Curie Group (GPMC). (1990) (15)
Hemoglobin Hotel-Dieu β599 ASP → GLY (Gl). A New Abnormal Hemoglobin with high Oxygen Affinity (1981) (15)
A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia (1992) (15)
Disseminated superficial porokeratosis after autologous bone marrow transplantation (1997) (15)
European undergraduate education in oncology. A report of the EORTC Education Branch. (1988) (14)
The labelling index of marrow myeloblasts: a predictive test for relapse of acute non-lymphoblastic leukemia. (1980) (14)
Acute myelo-monocytic leukaemia: a terminal complication of paroxysmal nocturnal haemolobinuria. (1975) (14)
Peroxidase activity in circulating mast cells in blast crisis of chronic granulocytic leukemia. Comparative studies with basophils and cutaneous mast cells. (1986) (14)
Effect of differentiating agents on modulation of MDR1 gene expression in multidrug-resistant hematopoietic HL60/DNR cell line. (1993) (14)
Toward an ethical consultation in intensive care? (2001) (14)
Treatment of chronic myelogenous leukemia in blast crisis and in accelerated phase with high- or intermediate-dose cytosine arabinoside and amsacrine. (1993) (14)
Fluorescence in situ hybridization analysis of minute marker chromosomes in leukemia with monosomy 7. (1995) (14)
Recombinant interferon-alpha-induced chorea and frontal subcortical dementia. (2002) (13)
Cost of complete remission induction in acute myeloblastic leukemia: evaluation of the cost-effectiveness of a new drug. (1992) (13)
SPONTANEOUS REMISSION IN ACUTE MYELOID LEUKAEMIA (1994) (13)
Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: A phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group (1996) (13)
Idiopathic thrombocytopenic purpura associated with Crohn's disease. (1998) (13)
Waldenström's macroglobulinaemia in a bird breeder: a case history with pulmonary involvement and antibody activity of the monoclonal IgM to canary's droppings. (1987) (12)
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients (2020) (12)
A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines (2004) (12)
PHA-induced blast colonies and kinetic parameters in acute myeloid leukemia. (1982) (12)
Sphenoid sinus localization of multiple myeloma revealing evolution from benign gammopathy (1997) (12)
Prospects and Problems in European Psychosocial Oncology (1987) (12)
Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia. (1985) (12)
Incidence of haematological malignancies in French Polynesia between 1990 and 1995. (1999) (11)
Prognostic value of in vitro uptake and retention of cytosine arabinoside in acute myelogenous leukemia. (1987) (11)
Overexpression of Cyclin D 2 in Chronic B-Cell Malignancies (2000) (11)
Two cases of epidemic mucormycosis infection in patients with acute lymphoblastic leukemia (1996) (11)
Respiratory Distress due to Tracheal Aspergillosis in a Severely Immunocompromised Patient (1998) (10)
Prognostic and diagnostic value of endogenous erythroid colony formation in essential thrombocythemia. (1998) (10)
Waldenström's macroglobulinemia with prominent splenomegaly and multiple immune disorders. (1993) (10)
[Methenolone in the treatment of medulary insufficiencies]. (1968) (10)
[New combination of epirubicine, bleomycin, vinblastine and prednisone (EBVP II) before radiotherapy in localized stages of Hodgkin's disease. Phase II trial in 50 patients]. (1988) (10)
Smoldering acute myelogenous leukemia in the elderly. (1999) (10)
Persistence of bone marrow lymphocytosis after induction treatment in common acute lymphoblastic leukemia: Marker analysis and significance (1986) (9)
Chemotherapy of acute myelogenous leukaemia. (1991) (9)
[Granulocytic sarcoma (chloroma) of the uvea]. (1983) (9)
[Chronic myelomonocytic leukemia in adults]. (1997) (9)
Chemotherapy of acute myelogenous leukemia. A review. (1992) (9)
Treatment of hairy cell leukaemia (HCL) with 2‐chlorodeoxyadenosine (2‐CdA): identification of parameters predictive of adverse effects (1997) (9)
Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML. (1999) (9)
Glutathione-S-transferases pi, alpha, mu and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemia. (1995) (8)
[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]. (1983) (8)
Allogeneic vs autologous stem cell transplantation according to cytogenetic features in AML patients (pts) <= 45 yrs old in first CR: Results of the EORTC-GIMEMA AML-10 trial (2001) (8)
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative Group. (1990) (8)
Enhancement of anti‐neoplastic activity of cytosine arabinoside against human HL‐60 myeloid leukemic cells by 3‐deazauridine (1991) (8)
[Aneurysm of the popliteal vein revealed by pulmonary embolism (author's transl)]. (1981) (8)
Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol. (1990) (7)
MLL cleavage occurs in approximately 5% of de novo acute myeloid leukemia, including in patients analyzed before treatment induction. (1997) (7)
[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination]. (2000) (7)
In vitro sensitivity of normal and leukemic myeloid clonogenic cells to hyperthermia: absence of selective effect. (1989) (7)
Allogeneic versus autologous bone marrox transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A) (1992) (7)
Response to deoxycoformycin in mature T cell malignancies. (1987) (7)
Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group. (1992) (7)
Patient Information and Participation (1990) (7)
[Hematological manifestations and complications in Sjögren's syndrome (author's transl)]. (1978) (6)
Angio-immunoblastic lymphadenopathy (AIL) or T-cell malignant lymphoma of AIL-type. A histopathological, immunohistochemical and ultrastructural study of 8 cases. (1988) (6)
Another case of trisomy 4 with double minute chromosomes in acute non-lymphocytic leukemia. (1995) (6)
[In vitro inhibition of granulopoiesis by beta-lactam antibiotics. Comparison of piperacillin, mezlocillin, ceftriaxone and ceftazidime]. (1986) (6)
[Histopathologic aspects of bone marrow in angioimmunoblastic lymphadenopathy]. (1984) (6)
T-cell depletion does not affect long-term human bone marrow culture. (1987) (6)
[Treatment of hyperuricemias in hematology using urate oxidase and allopurinol]. (1976) (6)
Treatment of relapsing and refractory adult acute myeloid leukemia according to in vitro clonogenic leukemic cell drug sensitivity. (1993) (6)
Acute myelomonocytic leukemia in a XYY man. (1993) (6)
[Cytological classification of adult acute leukemia (author's transl)]. (1976) (6)
DNA ligases in human leukemia. (1985) (6)
In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia. (1988) (6)
Subacute and chronic myelomonocytic leukemia. (1981) (6)
Treatment of patients with acute promyelocytic leukemia. The EORTC-LCG experience. EORTC Leukemia Cooperative Group. (1994) (5)
Deoxycoformycin in therapy of refractory lymphoid neoplasms. (1988) (5)
[Pseudolymphoma and lymphoproliferative syndromes in Gougerot-Sjögren syndrome (author's transl)]. (1978) (5)
Deoxyuridine-suppression test and bone marrow culture for the diagnosis of macrocytic refractory anaemias. (2009) (5)
Lymphocytic beta-glucuronidase in the lymphoproliferative syndromes. (1973) (5)
Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF) (1992) (5)
Busulfan versus 32P in polycythaemia vera. (1986) (5)
[Prolonged spontaneous remission of chronic lymphoid leukemia]. (1965) (5)
Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells. (1989) (5)
Incidence of haematological malignancies in French Polynesia between 1990 and 1995: Leukemia Research 23 (1999), 349–355 (2000) (5)
Early cytoreduction: a major prognostic factor in adult acute lymphoblastic leukemia. (1994) (5)
Training in Psychosocial Oncology (1990) (5)
[Sub-cortico-frontal encephalopathy and choreic movements related to recombinant interferon-alpha 2b]. (2002) (5)
Psychosocial Issues in Oncology: A Historical Perspective (1990) (5)
[Chromosome analyses in idiopathic acquired sideroblastic anemia. A study of 6 cases]. (1966) (5)
Acute colonic pseudo‐obstruction (ogilvie's syndrome) during induction treatment with chemotherapy and all‐trans‐Retinoic Acid for acute promyelocytic leukemia (1995) (4)
[Cryptosporidiosis in grafting of allogeneic bone marrow]. (1986) (4)
Chronic myelogenous leukemia with a Philadelphia chromosome resulting from a complex translocation (2; 9; 22), following an undifferentiated acute leukemia. (1983) (4)
[Acute leukemia with myelofibrosis]. (1972) (4)
[Centroblastic and centrocytic centroblastic malignant lymphomas, predominantly splenic (or primary of the spleen). Anatomo-clinical study of 17 cases]. (1987) (4)
Quality of life in hematological malignancies with brief reference to bone marrow transplantation. (1993) (4)
The EORTC trials for acute myelogenous leukemia (1996) (4)
DNA-topoisomerase I and II: biologic features and their role in drug resistance. (1993) (4)
[Continuous sedation until death. A French way for the end-of-life care?]. (2016) (4)
Glucocorticoid receptors and hormonal responsiveness of human blood and bone-marrow cells in non-lymphocytic leukemia. (1981) (4)
[Evolution of refractory anemias. Relations with myelo-monocytic leukemias]. (1974) (4)
A New Serum Lipoprotein Associated Erythrocyte Antigen which Reacts with a Monoclonal IgM (1976) (4)
In vitro depletion of clonogenic cells in adult acute lymphoblastic leukemia with a CD10 (anti-cALLA) monoclonal antibody. (1987) (4)
Fludarabine vs. High dose continuous chlorambucil : Interim analysis of a randomized phase II study in untreated B-cell chronic lymphocytic leukemia (B-CLL) (1996) (4)
[Thrombopenia caused by heparin. Review of the literature apropos of a personal case]. (1982) (3)
[Splenoma with accumulation of megakaryocytes during the course of an idiopathic myelofibrosis]. (1994) (3)
[Multicentric evaluation of MDR phenotype in leukemia: intermediate analysis of the French study]. (1996) (3)
Testing a predictive regression model for response in adult acute myeloid leukemia comparing two induction regimens of the E.O.R.T.C. -AML-5 and AML-6 trial. (1987) (3)
Understanding and overcoming resistance to chemotherapy in acute myeloid leukemia. (1998) (3)
The intercellular content of the three transcobalamins at various stages of normal and leukaemic myleoid cell development. (1975) (3)
[Hereditary chronic reticulosis in hepatosplenoadenomegalic form]. (1968) (3)
[A program for medical use of information systems. Validity of calculation of direct costs for the initial treatment of acute myeloblastic leukemia]. (1992) (3)
Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 years. (2000) (3)
[Bladder neoplasms and cyclophosphamide. Apropos pf 3 cases amd review of the literature]. (1996) (3)
Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study (1995) (3)
Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease (1991) (3)
[Small intestine lymphosarcoma after treatment of rheumatoid arthritis with chlorambucil]. (1972) (3)
[Subacute myelo-monocytic leukemia. Study of 27 cases and review of the literature]. (1972) (3)
[Hypervolemia in Waldenström's macroglobulinemia]. (1968) (3)
Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 years (2000) (3)
[Selective endoreduplication of a supernumerary chromosome in a case of multiple myeloma (Kahler's disease)]. (1967) (3)
[Acquired factor VII inhibitor: treatment using high-dose immunoglobulins, corticotherapy and plasma exchange]. (1988) (3)
Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial (2002) (3)
[Sjögren's syndrome with pseudolymphoma]. (1974) (3)
The EORTC trials for acute myelogenous leukemia. EORTC Leukemia Cooperative Group. European Organisation of Research and Treatment of Cancer. (1996) (3)
Lymph node interdigitating cell granuloma associated with non-Hodgkin's malignant lymphoma. A case report and review of the literature. (1989) (2)
[Meningo-encephalic localizations of non-hodgkinian lymphomas and Waldenstrom's macroglobulinemia]. (1977) (2)
High dose cytarabine in acute myelogenous leukemia. (1989) (2)
Oxytetracycline‐induced thrombocytopenic purpura (1993) (2)
[Peripheral T-cell malignant lymphomas. Clinical, morphologic and developmental features in 22 cases]. (1990) (2)
[Combination of AMSA-high dose cytosine arabinoside in acute leukemia]. (1985) (2)
[Myelomonocytic leukemia and pulmonary alveolar proteinosis]. (1973) (2)
[Megakaryocytic hyperplasia and qualitative abnormalities of the megakaryocyte-platelet series associated with acute myeloblastic leukemia]. (1968) (2)
On the origin of transcobalamins. (1977) (2)
High-Dose Cytosine-Arabinoside Plus AMSA for Reinduction or Consolidation-Maintenance in Acute Myelogenous Leukemia (1986) (2)
[Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)]. (1993) (2)
[Acute nonmyeloid leukemia in adults. Study of membrane antigens and terminal transferase. Diagnostic and prognostic value]. (1985) (2)
[Pernicious anaemia associated with Hashimoto's thyroiditis, Sjögren's syndrome and chondrocalcinosis (author's transl)]. (1978) (2)
[Autograft of bone marrow treated by immunotoxin T 101 for the treatment of T-cell leukemia and lymphoma. Initial clinical cases]. (1985) (2)
[Ceftazidime: advantages of continuous infusions in a patient with aplasia]. (1993) (2)
EORTC-GIMEMA AML8 protocol. A phase III study on autologous bone-marrow transplantation in acute myelogenous leukemia (AML). (1994) (2)
[Idiopathic acquired sideroblastic anemia: incorporation of glycine-2-C-14 into heme and globin of medullary erythroblasts in vitro]. (1967) (2)
[Culture of human bone marrow. Counts of colony forming granulocytes and macrophages in 100 patients without hematologic diseases]. (1975) (2)
[Glass adhesiveness and phagocytic activity of neutrophil leukocytes in myeloproliferative syndromes and refractory anemias]. (1973) (2)
New trends in the treatment of adult acute myeloid leukaemia (1997) (2)
GM-CSF and IL-3 in Myelodysplastic Syndromes at Low Risk of Developing Acute Leukemia (MDS-LR) (1992) (2)
Incidence rates of leukemia in French Polynesia (2012) (2)
[Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center]. (1996) (2)
Prediction of induction and duration of complete remission in acute myelogenous leukemia: value of clonogenic cell properties. (1987) (2)
[Splenic lympho-plasmocytic sarcomas discovered by exploratory laparotomy in 2 cases of cold agglutinin disease]. (1978) (2)
In vitro effect of rGM-CSF on proliferation and maturation of leukemic cells from patients with acute myelogenous leukemia. (1993) (2)
[Waldenstrôm's macroglobulinemia. Developmental and prognostic study]. (1975) (2)
Digestive Tract and Renal Small Vessel Hyalinosis, Idiopathic Nonarteriosclerotic Intracerebral Calcifications, Retinal Ischemic Syndrome, and Phenotypic Abnormalities (1986) (2)
Cell volume measurements in acute leukaemia: method and value for diagnosis and prognosis. (1976) (2)
Specific cutaneous involvement in B‐cell prolymphocytic leukaemia (1996) (1)
[Waldenstrom's hyperglobulinic purpura and Sjogren-Gougerot syndrome. 2 new cases]. (1961) (1)
Detection of residual disease in acute myeloid leukemia using light density gradients and culture assay. (1988) (1)
Chemotherapy of residual disease in adult acute lymphoblastic leukemia (ALL). A randomized study of the eortc leukemia lymphoma study group (1986) (1)
[Waldenström's macroglobulinemia with preserved antierythrocyte and antilipoprotein antibody activity]. (1975) (1)
[Subacute myelomonocytic leukemia. Apropos of 27 cases]. (1972) (1)
[Transcobalamines and lysozyme in leukemia and in myeloproliferative syndromes]. (1974) (1)
[Hypervitaminemia B-12 in leukemia and myeloproliferative syndromes]. (1968) (1)
[Biermer's disease without anemia, nor megaloblastosis. Value of the study of antibodies, vitamin assays, and the dU suppression test for the early diagnosis]. (1983) (1)
Expression of multidrug resistance-associated protein (MRP) gene in acute myeloid leukemia and correlation with expression of multidrug resistance (MDR1)gene: 108 (1994) (1)
The folacin load test (1973) (1)
High doses of cytosine arabinoside (HD-Ara-C) as reinforcement during remission of acute myeloid leukemia. (1982) (1)
[Objectives of the study of the quality of life in oncology]. (1986) (1)
[Incidence and severity of veno-occlusive diseases of the liver after bone marrow transplantation]. (1984) (1)
[Leukemic arthritis: a mode of recurrence of acute myelo-monocytic leukemia in adults]. (1977) (1)
Modulation of 1 beta d arabinofuranosylcytosine by n phosphonacetyl l aspartic acid and acivicin in l 1210 cells (1986) (1)
In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia. (1985) (1)
[Waldenström's macroglobulinemia with myeloid splenomegaly]. (1976) (1)
Chromosome 3q abnormalities in 43 untreated AML patients aged 15-60 years: preliminary results of the randomized AML-10 phase III trial of the EORTC and GIMEMA Leukemia Groups (2001) (1)
[Ultrastructural peroxidases and immunological markers in acute adult leukaemia: therapeutic applications (author's transl)]. (1982) (1)
[Orbital lymphoma and AIDS. Apropos of a case]. (1999) (1)
[Septicemia caused by Pseudomonas aeruginosa serotype O 16 in a hemato-oncology department. Review of 17 cases]. (1985) (1)
[A technic for "desensitization" in case of asparaginase anaphylaxis during acute leukemia]. (1973) (1)
In vitro hormonal responsiveness of human blood and bone marrow cells in non-lymphocytic leukemia. (1980) (1)
[Lysozyme in hematologic diseases]. (1975) (1)
[Reliability of DNA measurement after simultaneous staining of DNA and RNA by acridine-orange for flow-cytophotometry (author's transl)]. (1981) (1)
[Clinical conference: Transcobalamins and lysozyme in various evolving stages of chronic myeloid leukemia]. (1975) (1)
UNMAINTAINED CYTOGENETIC AND MOLECULAR REMISSION IN CHRONIC MYELOGENOUS LEUKAEMIA FOLLOWING TREATMENT BY INTERFERON (1996) (1)
Randomized phase II study LD-ARAC plus rhGM-CSF in advanced myelodysplasia (1993) (1)
[Acquired idiopathic sideroblastic anemia. (Study of 15 cases)]. (1965) (1)
[Diagnosis of preleukemic conditions and myelo-monocytic and atypical leukemias]. (1973) (1)
[Myelo-monocytic leukemia with sideroblastic anemia]. (1972) (1)
[Nutritional anemias]. (1984) (1)
[Distress during end-of-life: Ethical questions about sedation]. (2011) (1)
[Data collection from patients treated for Hodgkin's disease. Relation to quality of life]. (1986) (1)
[A particular risk of prolonged immunosuppressive treatment: a case of acute myelomonocytic leukemia after chlorambucil treatment of severe rheumatoid arhtritis]. (1976) (1)
[Macrocytic animia due to the combination trimethoprim-sulfamethoxazole]. (1975) (1)
[Sarcomatous and leukemic forms of Waldenström's macroglobulinemia]. (1975) (1)
Informed Consent and Cancer Clinical Research (1990) (1)
The Palliative Care Centre of Hôtel-Dieu Hospital (2004) (1)
[Cutaneous necrosis of the breast: a complication of oral anticoagulant treatment]. (1983) (1)
[Early evaluation of therapeutic response in acute lymphoblastic leukaemia. A study of cytoreduction in blood and bone marrow (author's transl)]. (1982) (1)
Pentasomy 13q in a case of acute myelogenous leukemia (Mo). (1998) (1)
[Pregnancy and hematologic malignancies: a therapeutic approach]. (1994) (1)
[Necrotizing myelopathy after intrathecal methotrexate]. (1997) (1)
[Search for anti-intrinsic factor antibodies in the diagnosis of Biermer's anemia]. (1975) (1)
[Expansion of erythropoiesis and granulopoiesis after bone marrow grafts]. (1986) (1)
Hemoglobin Hotel-Dieu beta 99 Asp replaced by Gly (g1). A new abnormal hemoglobin with high oxygen affinity. (1981) (1)
EORTC Leukemia Group trials on acute myeloid leukemias: an overview. (1990) (1)
[Assays in delayed hypersensitivity in the course of Hodgkin's disease]. (1970) (1)
[Prediction of the response to chemotherapy in acute leukemia through in-vitro incorporation of tritiated thymidine]. (1974) (0)
[Trials of modulating the MDR1 phenotype in malignant hemopathies]. (1994) (0)
Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA. (1991) (0)
PP64. Resource utilisation in intensive chemotherapy, autologous versus allogeneic bone marrow transplantation in acute myeloid leukemia (1997) (0)
[Psychosocial repercussions of the the treatment of Hodgkin's disease. Assessment by questionnaire with 150 patients]. (1986) (0)
Contents, Vol. 88, 1992 (1992) (0)
[Hematological aspects of Sjögren's syndrome. Foreword]. (1978) (0)
[Value of lysozyme determination in hematological practice]. (1974) (0)
High-dose ara-C (HDARAC) + amsa as reinduction (RI) or first consolidation-maintenance (CM) treatment in AML (1986) (0)
[Letter: Acute myeloblastic leukemia: prevision of the efficiency by the combination of daunorubicin-cytosine-arabinoside]. (1975) (0)
[Leukocytic alkaline phosphatase in acute leukemia and chronic myeloproliferative syndrome]. (1968) (0)
[GLOBAL AND CHRONIC MEDULLARY INSUFFICIENCY OF THE ADULT]. (1964) (0)
[HEPATIC ANGIOMA AND CIRRHOSIS IN THE RENDU-OSLER DISEASE]. (1964) (0)
IgM allergic shock with complement consumption and cross reaction in anesthesia. (1978) (0)
[Non-myelomatous IgG and IgA paraproteinemias]. (1968) (0)
[Double coloration in the cytochemistry of acute leucosis]. (1977) (0)
[AML-6 and AML-7 studies on the treatment of acute myelocytic leukemia. Cyclic alternating chemotherapy during remission, and induction of remission and survival of elderly patients]. (1985) (0)
[Development and prognostic significance of cytochemical aspects in acute leukemia]. (1969) (0)
[The prognosis factors of subacute and chronic myelo-monocytic leukemias (author's transl)]. (1982) (0)
Treatment Adult Acute to in vitro C of Relapsing and Refractory M yeloid Leukemia According .onogenic Leukemic Cell Drug Sensitivity (1993) (0)
transplantation or chemotherapy Thrombocytopenia in venocclusive disease after bone marrow (2011) (0)
[AGAMMAGLOBULINEMIA OF AN INFANT WITH AN APPARENTLY RETARDED BIOLOGIC APPEARANCE]. (1965) (0)
[In vitro study of sensitivity of leukemic cells to cytotoxic drugs (anticytogram)]. (1975) (0)
[The transcobalamins]. (1973) (0)
[Transformation of malignant non-Hodgkin's lymphomas from low- to high-grade malignancy]. (1986) (0)
Prognostic impact of cytogenetics in untreated AML patients aged 16-60 years: preliminary results of the randomized AML-10 phase III trial of the EORTC and GIMEMA Leukemia Groups (2001) (0)
[Global hypocorticism. Hypoaldosteronism and pseudo-hypoaldosteronism in infants. 3 cases]. (1965) (0)
Modulation of 1-ÃŸ-D-Arabinofuranosy Icytosine Metabolism by Thymidine in Human Acute Leukemia1 (2006) (0)
[Anaemia induced by vitamin B12 or folate deficiency: diagnostic value of the "dU suppression" test (author's transl)]. (1978) (0)
[Post-hepatitic bone marrow aplasia]. (1971) (0)
[Biermer's anemia with chronic lymphoid leukemia and hemolysis with autoantibodies]. (1975) (0)
[Undifferentiated naso-pharyngeal carcinoma of the Schmincke-Regaud type. Apropos of 3 cases]. (1976) (0)
[PAS staining of normal and leukemic lymphocytes]. (1967) (0)
Letter: HL-A and pernicious anemia. (1975) (0)
[Clinical conference: Histaaminemia in myeloproliferative syndromes]. (1975) (0)
[Primary hemochromatosis and folate deficiency]. (1973) (0)
[Platelet function study in subacute myelo-monocytic leukemia and refractory anemia]. (1972) (0)
[Intra-alveolar hemorrhage during treatments of acute leukemia]. (1992) (0)
[Glucocorticoid receptors and leukemia (author's transl)]. (1981) (0)
[Immunoblastosarcoma of the orbit]. (1978) (0)
[Value of plasma exchange in the management of acute immunoallergic thrombocytopenic purpura (author's transl)]. (1981) (0)
[Pleiotropic resistance in malignant hemopathy: genes involved and modulation]. (1993) (0)
[Toxicity of high-dose methotrexate. Pharmacokinetic data]. (1982) (0)
[Thrombopenic purpura and hyperthyroidism]. (1973) (0)
[Vascular complications of vincristine]. (1979) (0)
[Leukemic lymphohistiocytosis ("reticuloendotheliosis")]. (1973) (0)
[Therapeutic collaboration in the patient care team]. (1986) (0)
[Importance of laparotomy and splenectomy in the course of Hodgkin's disease]. (1970) (0)
[The evolution of idiopathic autoimmune hemolytic anemia]. (1973) (0)
[Nodular lymphoma of the spleen]. (1970) (0)
[Can one discuss with the patients their imminent death?]. (2003) (0)
[Angioimmunoblastic lymphadenopathy: clinical manifestations, diagnosis and clinical course]. (1982) (0)
Intensive Chemotherapy Followed by Stem Cell Transplantation for the Treatment of Myelodysplastic Syndromes (2001) (0)
[Diagnosis methods in Sjögren's syndrome (author's transl)]. (1978) (0)
[Pseudoreticulosarcoma revealing initially acute chronic myeloid leukemia]. (1972) (0)
[Method of teaching hematology with diagnostic data cards]. (1972) (0)
[MEGALOBLASTIC ANEMIA SYMPTOMATIC OF OCCULT MALABSORPTION]. (1964) (0)
[Comparison of reactivity and heterospecificity of normal and leukemic human cells towards animal anti-thymocyte serums. Cytotoxic activity]. (1974) (0)
[Sideroblasts and staining of erythroblasts by PAS in different categories of anemias]. (1965) (0)
[Psychological implications of cancer. II. Consequences of treatment and modality of adaptation]. (1988) (0)
[Peroxidase activity in blast cells of acute myeloid leukemia cultured in methylcellulose. Ultrastructural study]. (1984) (0)
[THE ASSOCIATION OF A LYMPHOID LEUKOSIS WITH AN EPITHELIAL CANCER]. (1964) (0)
[Transcobalamins in megaloblastic anemias]. (1975) (0)
[Lymphoproliferative syndrome with production of purely intracellular IgM macroglobulin]. (1971) (0)
[Primary acute leukemia with Philadelphia chromosome]. (1978) (0)
In vitro reversal of multidrug resistance (MDR1) in hematopoietic cell lines by GF120918, a new modifying agent of P-glycoprotein: 77 (1994) (0)
[Massive infiltration of the pericardium in the course of malignant lymphomas]. (1961) (0)
[VALUE OF LYMPHOGRAPHY IN MALIGNANT HEMOPATHIES]. (1964) (0)
[SECONDARY MEDULLARY INSUFFICIENCY OF THE ADULT]. (1964) (0)
The impact of anthracyclines on feasibility of subsequent autologous or allogeneic transplantation and induced marrow toxicity: interim results of the EORTC - GIMEMA AML-10 trial (2001) (0)
[Leukemia in refractory anemia after treatment of psoriasis. Role of retinoids and PUVA therapy?]. (1983) (0)
Evaluation and Chemotherapy of Residual Disease in Acute Leukemia (1984) (0)
[Use of a bovine carotid artery graft for anticancer chemotherapy]. (1979) (0)
[Acute myeloid leukemia secondary to chronic lymphoid leukemia]. (1984) (0)
[Nosology and diagnosis of myeloproliferative syndrome]. (1968) (0)
[Study of various erythrocytic anomalies in leukemia]. (1970) (0)
Subject Index, Vol. 88, 1992 (1992) (0)
[Autoantibody-induced hemolytic anemia in chronic lymphocytic leukemia]. (1982) (0)
[Myeloid splenomegaly and Biermer's anemia]. (1970) (0)
[Pyoderma gangrenosum in myeloid splenomegaly: a case]. (1988) (0)
[Folate deficiency and neurologic disorders]. (1975) (0)
[Primary and secondary thrombocythemia: apropos of 39 cases]. (1968) (0)
Eortc-gimema AML8 protocol. Parallel phase III trials in acute myelogenous leukemia (AML) (1993) (0)
[Non-pernicious megaloblastic anemias]. (1965) (0)
[AML-6 study of the value of cyclic alternating chemotherapy during remission in acute myelocytic leukemia]. (1985) (0)
[Increased hematological toxicity of antineoplastic drugs with simultaneous androgenotherapy (author's transl)]. (1977) (0)
A randomized study in stage III B and IV Hodgkin's disease comparing eight courses of MOPP versus an alternation of MOPP with ABVD: an EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial (1994) (0)
Phase I-II trial of Seraspenide (AcSDKP): a supressor of myelopoiesis protects against chemotherapy myelotoxicity (version 10 february 1993) (1994) (0)
[Use of hematopoietic growth factors in oncology]. (1991) (0)
[Letter: Hypouricemia in Hodgkin's disease]. (1975) (0)
[Apropos of an unusual form of acquired hemolytic anemia]. (1966) (0)
[Clinical conference: Modes of blast transformation in chronic myeloid leukemia]. (1975) (0)
[Treatment of Hodgkin's disease by segmental radiotherapy extended above and below the diaphragm]. (1972) (0)
[Diagnostic and prognostic value of the assay of lysozyme in acute leukemia (author's transl)]. (1979) (0)
[In vitro incorporation of tritiated thymidine in acute leukemia and response to chemotheraphy (author's transl)]. (1975) (0)
Relationship between vitamin A and malignancy in cancer patients. (1985) (0)
Quality of Life as a Major Determinant of Medical Decision-Making (1997) (0)
[The treatment of bone marrow aplasia]. (1965) (0)
[Histological criteria of idiopathic acquired sideroblastic anemia]. (1969) (0)
[Accelerated constrictive evolution of a septic pericarditis]. (1959) (0)
[Hodgkin's disease: the value of prognostic criteria and of the combination of radiotherapy and chemotherapy in localised lymphoid stages (I and II). 94 patients undergoing laparotomy (author's transl)]. (1978) (0)
In vitro effect of anti-calla and anti-ba1 monoclonal antibodies on clonogenic leukemic cells in acute lymphoblastic leukemia (1986) (0)
[Certainly malignant erythremias and minimal erythroleukemias (apropos of 11 cases)]. (1968) (0)
Postremission Therapy: The Role of Allogeneic Bone Marrow Transplantation in Acute Myelogenous Leukemia: An Analysis of the AML8A EORTC-GIMEMA Protocol (1997) (0)
[Folic acid absorption test]. (1973) (0)
[The relationship of a married couple, defense mechanism when faced with the anxiety of death]. (1988) (0)
[Radiation-induced sternal tumors: value of myocutaneous flap of the latissimus dorsi]. (1992) (0)
[Psychological implications of cancer. I. Psychological consequences of the disease]. (1988) (0)
[Lymphoblastic leukemia and immunological markers]. (1987) (0)
Autologous Bone Marrow Transplantation with Marrow Decontaminated by Immunotoxin T 101 in the Treatment of Leukemia and Lymphoma (1985) (0)
In vitro sensitivity of CFU-L to cytosine arabinoside (Ara-C). (1982) (0)
[SPLENECTOMY IN CONGENITAL HEMOLYTIC ANEMIA]. (1964) (0)
[Effects of blood letting in idiopathic acquired sideroblastic anemia]. (1967) (0)
[Letter: Use of urate oxidase and allopurinol as hypouricemic agents in hematology]. (1976) (0)
The Education Branch of EORTC and its new publication "Reviews in Oncology". A presentation. (1987) (0)
[Acute relapse of idiopathic thrombopenic purpura during infectious episodes]. (1972) (0)
GM-CSF and IL-3 in Myelodysplastic Svndromes at Low Risk of Develoointz (1992) (0)
PROGNOSTIC VALUE OF THE DURATION OF POST‐INDUCTION NEUTROPENIA IN ACUTE MYELOGENOUS LEUKAEMIA (1989) (0)
GM-CSF FOR INDUCTION OF ACUTE MYELOID LEUKEMIA (2017) (0)
Four Cases Of Acquired Von Willebrand's Syndrome Associated With Monoclonal Gammapathy (1981) (0)
[Letter: Spleno-lymph nodal lympho-plasmocytic a sarcomas discovered by laparotomy during hemolytic anemia with antibodies]. (1976) (0)
[Prevention of infectious complications of acute leukemias: place of general and intestinal antibiotic therapy]. (1973) (0)
[Palliative care: a need and not a fashion]. (1991) (0)
In memoriam Mildred Scheel (1985) (0)
[Will the known causes of leukemia be finally recognised?]. (1978) (0)
[So-called periodic disease]. (1958) (0)
Management of Fever in Adult Hematological Neutropenic Patients: Comparison of Tazocillin + Aminoside versus Ceftazidime + Aminoside in 466 Febrile Episodes (1998) (0)
Post-Remission Treatment with Autologous or Allogeneic Bone Marrow Transplantation or Intensive Chemotherapy in Younger AML Patients: Long-Term Follow-up Results of the EORTC/Gimema AML-8A Study (2016) (0)
[Subacute myelo-monocytic leukemia. Cyto- and biochemical study of granulocytic and monocytic lines]. (1972) (0)
[Angioimmunoblastic lymphadenopathy. Different histopathological forms of lymph node involvement]. (1983) (0)
[Cytochemical modifications of leukemia leukoblasts in short-time culture]. (1969) (0)
[Systematic screening for Sjögren's syndrome in patients with various blood diseases]. (1978) (0)
[Cytochemical modifications during the evolution of acute leukemia]. (1967) (0)
[Sternal puncture with a fine needle. An effective and not very painful technic]. (1985) (0)
Prediction of the duration of complete remission in acute myeloid leukemia by in vitro drug sensitivity assay (1986) (0)
[Interdigitating reticulum cell hyperplasia simulating histiocytosis X of the lymph nodes]. (1987) (0)
[Hematologic aspects of cirrhosis]. (1966) (0)
[Clinical conference: Histamine and basophils after cellular separation on albumin gradient]. (1975) (0)
Book Review – Buchbesprechung – Livre nouveau (1975) (0)
[Treatment of acute myeloblastic leukemia]. (1993) (0)
[Malignant lympho-epithelioid lymphoma (Lennert's lymphoma)]. (1977) (0)
[Aetiological study of aplastic anaemia: analysis of sex, age, profession and habitat in 251 patients (author's transl)]. (1978) (0)
Chemotherapy of malignant blood diseases. (1991) (0)
[Treatment of high malignancy lymphoma with intensive short-term chemotherapy using the MACOP-B regimen]. (1993) (0)
[Clinical studies of the erythrocytosis produced by a new hemoglobin with oxygen affinity : Hb Hôtel-Dieu alpha 2A beta 2 Asp replaced by Gly (author's transl)]. (1981) (0)
[Idopathic sideroblastic anemia: platelet function and ultrastructural findings]. (1971) (0)
[2 atypical cases of Felty's syndrome with agranulocytosis]. (1975) (0)
[From quality of life to palliative care in cancerology]. (2013) (0)
Curative vs. Palliative treatment in oncology (1993) (0)
[Sideroblastosis and erythroblastic P.A.S. in leukemias and myeloproliferative syndromes]. (1967) (0)
[Sideroblastic anemia in young subjects of the hypochromic polyglobulia type]. (1965) (0)
Post remission treatment in acute myelogenous leukaemia in first remission. The EORTC experience. EORTC Leukemia Cooperative Group. (1989) (0)
Rationale of intensive chemotherapy associated with autologous bone marrow transplantation. (1985) (0)
Achievements in the treatment of acute myelogenous leukemia (AML) (1997) (0)
Book review: Psycho‐Oncologie. Darius Razavi and Nicole Delvaux. Published by Masson, Paris, 1994. Price: FF150 (1996) (0)
Immunodépression et cancer (1983) (0)
[A case of acute lymphoblastic leukemia revealed by the presence of pleuropericarditis]. (1965) (0)

This paper list is powered by the following services:

Robert A. Zittoun's Academic­Influence.com Rankings

Why Is Robert A. Zittoun Influential?

Robert A. Zittoun's Published Works

Published Works

Robert A. Zittoun's AcademicInfluence.com Rankings